Technology is rapidly advancing, and artificial intelligence (AI) has made significant strides in healthcare. AI-powered tools and applications have been developed to aid healthcare professionals in diagnosing and treating diseases, streamlining administrative tasks, and improving patient care. However, as AI becomes more accessible, there is a growing concern about how much AI can do.

Researchers aimed to test the feasibility of a DTx program for patients with cancer, as measured by engagement, retention, and acceptability. In addition, we explored the effects of the program on cancer-related QoL. The high retention, employment, and acceptability found in this study demonstrated that multidisciplinary DTx is feasible for patients with cancer.

Research has shown that 74% of all U.S. adults use the Internet, and 61% have looked for health or medical information on the Internet. Additionally, 49% have accessed a website that provides information about a specific medical condition or problem. Many people get health information from the Internet but are left on their own to determine if it’s credible. This is one area where pharma companies can restore trust and excel.